Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference
September 05 2023 - 4:00PM
Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it
will present at the Barclays Global Consumer Staples Conference on
Thursday, September 7, 2023 at 3:00 p.m. ET. All interested
parties may access a live webcast of this event at
www.prestigeconsumerhealthcare.com under the "Investors” section
and the "Events and Presentations" tab, or by using the following
link:
https://ir.prestigebrands.com/events-presentations/events
For those unable to participate during the live webcast, a
replay option will be available on the Company’s website following
the event.
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare is a leading consumer healthcare
products company with sales throughout the U.S. and Canada,
Australia, and in certain other international markets. The
Company’s diverse and iconic portfolio of brands include Monistat®
and Summer’s Eve® women's health products, BC® and Goody's® pain
relievers, Clear Eyes® and TheraTears® eye care products, DenTek®
specialty oral care products, Dramamine® motion sickness
treatments, Fleet® enemas and glycerin suppositories, Chloraseptic®
and Luden's® sore throat treatments and drops, Compound W® wart
treatments, Little Remedies® pediatric over-the-counter products,
Boudreaux’s Butt Paste® diaper rash ointments, Nix® lice treatment,
Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte®
rehydration products and the Fess® line of nasal and sinus care
products in Australia. Visit the Company's website at
www.prestigeconsumerhealthcare.com.
Investor Relations Contact
Phil Terpolilli, CFA, 914-524-6819
irinquiries@prestigebrands.com
Prestige Consumer Health... (NYSE:PBH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Prestige Consumer Health... (NYSE:PBH)
Historical Stock Chart
From Jul 2023 to Jul 2024